Sample
Serum, plasma, tissue homogenates and other biological fluids.
Intended Use
For quantitative detection of Tumor Marker CA724 in serum, plasma, tissue homogenates and other biological fluids.
Contents of Kit
1. ELISA Microplate: (Dismountable) 8×12, 2-8°C/-20°C
2. Lyophilized Standard: 2 vial, 2-8°C/-20°C
3. Biotin-labeled Antibody (Concentrated, 100X): 1 vial, 120 μl, 2-8°C (Avoid Direct Light)
4. HRP-Streptavidin Conjugate (SABC, 100X): 120 μl, 2-8°C (Avoid Direct Light)
5. TMB Substrate: 10 ml, 2-8°C (Avoid Direct Light)
6. Sample Dilution Buffer: 20 ml, 2-8°C
7. Antibody Dilution Buffer: 10 ml 2-8°C
8. SABC Dilution Buffer: 10 ml, 2-8°C
9. Stop Solution: 10 ml, 2-8°C
10. Wash Buffer(25X): 30 ml, 2-8°C
11. Plate Sealer: 5 pieces
12. Product Description: 1 copy
Storage
2-8°C (for sealed box), please do not freeze! See kit label for expiry date.
Detection Range
15.625-1000 pg/ml
General Description
Tumor Marker CA724 is a glycoprotein biomarker used in the diagnosis and monitoring of certain cancers, particularly gastrointestinal tumors such as gastric and colorectal cancers. It is a soluble form of mucin-like glycoprotein MUC16, also known as cancer antigen 724 (CA724). Elevated levels of CA724 in serum or other bodily fluids are associated with cancer progression and poor prognosis. Tumor Marker CA724 is commonly measured in clinical settings as part of cancer screening and management protocols.
Citations
Publication ()
Have you cited DEIA-JY25077 in a publication?
Let us know and earn a reward for your research.